The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human study of JNJ-79635322 (JNJ-5322), a novel, next-generation trispecific antibody (TsAb), in patients (pts) with relapsed/refractory multiple myeloma (RRMM): Initial phase 1 results.
 
Niels van de Donk
Consulting or Advisory Role - Adaptive Biotechnologies (Inst); Amgen (Inst); Bayer (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Janssen (Inst); MERCK (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Amgen (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Cellectis (Inst); Janssen (Inst); Novartis (Inst)
 
Gala Vega
No Relationships to Disclose
 
Aurore Perrot
Honoraria - Abbvie; Amgen; BMS; GlaxoSmithKline; Janssen; Pfizer; Sanofi; Takeda
Research Funding - Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Janssen
 
Sébastien Anguille
No Relationships to Disclose
 
Albert Oriol
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Pfizer; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Sanofi
 
Monique Minnema
Consulting or Advisory Role - Janssen-Cilag; Pfizer
Speakers' Bureau - Jassen Cilag; Siemens
Research Funding - BeiGene
Travel, Accommodations, Expenses - BeiGene; Janssen-Cilag
 
Martin Kaiser
Honoraria - Janssen Oncology; Sanofi
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Pfizer; Poolbeg; Regeneron; Roche; Sanofi
Research Funding - Celgene (Inst)
 
Hans Lee
Consulting or Advisory Role - Abbvie; Alexion Pharmaceuticals; Allogene Therapeutics; Bristol Myers Squibb; GlaxoSmithKline; Janssen Research & Development; Menarini Silicon Biosystems; Pfizer; Regeneron; Sanofi; Takeda
Research Funding - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Regeneron; Takeda
 
Alfred Garfall
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; CDR-Life; GlaxoSmithKline; Janssen Oncology; Novartis; Regeneron; Smart Immune
Research Funding - crispr therapeutics (Inst); Janssen Oncology (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patent in the field of CAR T cell therapy
Travel, Accommodations, Expenses - Janssen
 
Jeffrey Matous
Consulting or Advisory Role - Johnson and Johnson
 
Larysa Sanchez
Honoraria - Janssen Research & Development
Consulting or Advisory Role - Janssen Research & Development; Pfizer; Sanofi
Research Funding - Janssen Research & Development (Inst)
 
Azra Borogovac
Consulting or Advisory Role - AADi (I); Bayer (I); Deka Biosciences (I); Exelixis (I); Gilead Sciences (I); Johnson & Johnson/Janssen; Pfizer (I); Seattle Genetics/Astellas (I)
Speakers' Bureau - Johnson & Johnson/Janssen; Sanofi (I)
 
Lionel Karlin
Employment - Aguettant (I)
Honoraria - Abbvie; Abbvie; Amgen; Celgene; Janssen-Cilag; Pfizer; sanofi; sanofi; Takeda
Consulting or Advisory Role - Abbvie; Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Pfizer; Pfizer; Takeda
Travel, Accommodations, Expenses - Amgen; Janssen-Cilag; Pfizer; Sanofi; Takeda
 
Saad Usmani
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb/Celgene; Genentech; GlaxoSmithKline; Janssen Oncology; Oricell Therapeutics; Regeneron
Research Funding - Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Gracell Therapeutics; Janssen Oncology; K36 Therapeutics
 
Joseph Weidman
Employment - Johnson & Johnson
Stock and Other Ownership Interests - BBIO; BeiGene; DSNKY; FOLD; GlaxoSmithKline; Johnson & Johnson; MDGL; Pfizer; Regeneron
Patents, Royalties, Other Intellectual Property - Johnson & Johnson
 
Sangmin Lee
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
Patents, Royalties, Other Intellectual Property - JBI Inc.
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Kite, a Gilead company; Pfizer; Regeneron; Roche/Genentech; Stemline Therapeutics; Takeda
 
Paula Rodríguez-Otero
Honoraria - Abbvie; Celgene; GlaxoSmithKline; H3 Biomedicine; Janssen; Pfizer; Regeneron; Roche/Genentech; Sanofi
Consulting or Advisory Role - Abbvie; BMS; GlaxoSmithKline; Janssen; Pfizer; Roche; Sanofi
Speakers' Bureau - BMS; GlaxoSmithKline; Janssen; Sanofi
Travel, Accommodations, Expenses - Pfizer
 
Cyrille Touzeau
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Janssen; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Janssen; Pfizer; Takeda
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen; Pfizer; Sanofi
 
Rakesh Popat
Honoraria - Abbvie; BMS; Celgene; GlaxoSmithKline; Johnson & Johnson/Janssen; Pfizer
Consulting or Advisory Role - Galapagos NV; GlaxoSmithKline; Janssen; Regeneron; Roche; Sanofi
Speakers' Bureau - Pfizer
Research Funding - GlaxoSmithKline (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen